Risk Factors for Death Among 120,804 Hospitalized Patients with Confirmed COVID-19 in São Paulo, Brazil.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
31 05 2021
Historique:
received: 17 12 2020
accepted: 17 04 2021
pubmed: 2 6 2021
medline: 28 1 2022
entrez: 1 6 2021
Statut: epublish

Résumé

São Paulo is a state in Brazil with one of the highest numbers of confirmed and severe cases of coronavirus disease (COVID-19), with an incidence of 294 hospitalizations per 100,000 inhabitants. We report the clinical characteristics and outcomes of 120,804 hospitalized patients with confirmed COVID-19 from February 26 to October 10, 2020, in São Paulo. Characteristics of patients who died and survived were compared using a survival analysis. The median age was 60 years (interquartile range [IQR], 47-72), 67,821 (56.1%) were men, and 61,659 (51.0%) were white. Most hospitalized patients (79,812; 66.1%) reported one or more comorbidities, 41,708 (34.5%) hospitalized patients were admitted to intensive care units, and 33,079 (27.4%) died. Men (hazard ratio [HR], 1.22; 95% confidence interval [CI], 1.18-1.25), elderly individuals (HR, 3.85; 95% CI, 3.68-4.02), and patients with chronic cardiovascular disease including hypertension (HR, 1.05; 95% CI, 1.02-1.08), chronic lung disease (HR, 1.38; 95% CI, 1.31-1.45), diabetes mellitus (HR, 1.14; 95% CI, 1.11-1.18), and chronic neurological disease (HR, 1.48; 95% CI, 1.41-1.55) were at higher risk for death from COVID-19.

Identifiants

pubmed: 34061773
doi: 10.4269/ajtmh.20-1598
pii: tpmd201598
pmc: PMC8274770
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-92

Auteurs

Patricia Vieira da Silva (PVD)

1Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Silvano Barbosa de Oliveira (SB)

2Pan American Health Organization, Brasília, Brazil.
3World Health Organization, Brasília, Brazil.
4University of Brasilia, Brasília, Brazil.

Juan José Cortez Escalante (JJC)

2Pan American Health Organization, Brasília, Brazil.
3World Health Organization, Brasília, Brazil.

Maria Almiron (M)

2Pan American Health Organization, Brasília, Brazil.
3World Health Organization, Brasília, Brazil.

Daniel Henrique Tsuha (DH)

1Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Helena Keico Sato (HK)

5Epidemiological Surveillance Center "Prof. Alexandre Vranjac" of the São Paulo State Department of Health, São Paulo, Brazil.

Paulo Rossi Menezes (PR)

6Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil.

Regiane Cardoso de Paula (RC)

6Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil.

Tatiana Lang D'Agostini (TL)

6Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil.

Julio Croda (J)

1Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
7Oswaldo Cruz Foundation, Campo Grande, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH